Clinical Operations

Decentralized trial handoff sheet for coordinators and patients

A coordinator playbook for hybrid trial handoff sheets that clarify remote steps, site visits, local tasks, and next-action owners.

A decentralized trial handoff sheet keeps coordinators and patients aligned on what happens remotely, what happens at the site, what may happen locally, and who owns each next action.

In this guide

Key points

  • Hybrid and decentralized workflows need patient-facing and coordinator-facing handoff views.
  • Each remote, local, or site-based step should have an owner, timing expectation, support contact, and missed-step recovery path.
  • The handoff sheet should reduce confusion without promising remote convenience beyond what the approved workflow supports.

Decentralized elements add handoffs

Decentralized trial elements can make participation easier, but they also create more handoff points. A patient may interact with a coordinator, telehealth staff, local provider, home health vendor, lab, device-support team, shipping workflow, and the research site.

FDA's final guidance on decentralized elements says trial activities may occur remotely at locations convenient for participants, including telehealth visits, in-home visits, and visits with local health care providers.

Create two versions

The coordinator version should include workflow owners, approved language, timing, escalation rules, technology support, missed-step handling, and documentation expectations.

The patient version should be shorter: what happens next, who may contact you, what may be remote, what may require travel, and where to ask questions.

Avoid overpromising convenience

Remote prescreening does not mean the whole study is remote. A handoff sheet should explain when screening, procedures, labs, baseline visits, or follow-up may require travel or local-provider coordination.

The safest wording is specific: some steps may happen remotely, while other steps may require the research site or another approved location.

Connect the handoff to the queue

The handoff sheet is useful only if the coordinator queue shows the current owner and next action. If the device shipment is late, the local lab order is incomplete, or the patient is waiting for a callback, the workflow should show that blocker.

A weekly review can compare the handoff sheet against actual queue blockers. If the same step keeps failing, the fix may be vendor instructions, patient-facing language, owner assignment, or escalation timing rather than another reminder to coordinators.

TrialsNest can help teams keep those handoffs visible across public interest, coordinator follow-up, study status, and sponsor-facing recruitment visibility while approved study systems remain the source for regulated study records.

Illustrative example

Case-style example

A hybrid study allows remote follow-up but requires in-person screening. Recruitment copy emphasizes convenience, and patients arrive at scheduling expecting no site travel.

Coordinators repeatedly reset expectations after the patient has already submitted interest.

The handoff sheet separates remote prescreen, site screening, local-provider steps, and follow-up options before scheduling begins.

Field note

The handoff sheet is where vague language like hybrid-friendly becomes operational: who calls, what happens remotely, what still requires travel, and what the patient should wait for before taking action.

Common mistakes

Calling the study remote when only prescreening is remote

Patients need to know whether screening, baseline visits, procedures, or follow-up steps still require site travel.

Leaving vendors outside the workflow

If a device, lab, shipping, home health, or telehealth vendor touches the participant experience, the coordinator needs a handoff owner and escalation path.

Before you start

  • Map each step by location: Label the activity as remote, in-home, local provider, local lab, research site, or study-team review.
  • Assign the owner: Name the coordinator, investigator, vendor, local provider, sponsor contact, or site team responsible for the next action.
  • Write the patient version: Give patients a short sequence: what happens next, who may contact them, what may be remote, what may require travel, and where questions should go.
  • Which step happens next, and who contacts the patient?
  • Which activities are remote, local, in-home, or site-based?
  • What should the patient do if the remote, local, or shipping step does not happen on time?
Sources and editorial notes

Published .

Operational workflow guidance only. Decentralized trial design, participant instructions, and study-specific requirements should follow the approved protocol and study-team review.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading